GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA2A, AKR1B1, APP, AR, CDC25B, CSNK2A1, CYP1B1, EGFR, ESR1, ESRRA, F3, FABP3, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MIF, MMP12, MMP2, MMP9, NUAK1, PIM1, PTGES, RELA, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
12.8554 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, F3, FLT3, GPER1, GPR35, GSK3B, HSPA1A, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
12.8554 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, F3, FLT3, GPER1, GPR35, GSK3B, HSPA1A, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
12.8554 |
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, ALOX15, ALPL, APP, AR, AXL, CA2, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, GSK3B, HSD17B2, HSPA1A, IGF1R, INSR, KCNH2, KDR, MMP2, MMP9, PPARA, PTGES, RELA, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TYR |
11.6946 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CSNK2A1, CYP1B1, EGFR, F10, F3, FLT3, GPER1, GPR35, GSK3B, HSPA1A, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
11.5108 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CYP1B1, EGFR, F10, F3, FLT3, GPER1, GPR35, HSPA1A, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, PTPN1, RELA, SRC, TEK, XDH |
10.8341 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, ALOX15, ALPL, APP, AR, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, GSK3B, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, PPARA, PTGES, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TYR |
10.7288 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA12, CA2, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, F10, F3, FABP3, FABP4, FLT3, GPER1, GPR35, GSK3B, HSD17B1, HSD17B2, HSD17B3, HSPA1A, INSR, KCNH2, KDR, MAOA, MET, MIF, PPARA, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
10.549 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FLT3, GPER1, GPR35, GSK3B, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
10.5108 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, F3, FLT3, GPER1, GPR35, GSK3B, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, NUAK1, PTPN1, RELA, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
10.4779 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, F10, F3, FLT3, GPER1, GPR35, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP9, NUAK1, PTPN1, RELA, SRC, TEK, XDH |
10.3709 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, F3, FLT3, GPER1, GPR35, GSK3B, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, NUAK1, PTPN1, RELA, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
10.3463 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AR, AXL, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FABP3, GPER1, GSK3B, HSD17B2, IGF1R, INSR, MMP2, MMP9, PPARA, PTGES, RELA, RORC, SLC6A4, SRC, TEK, TYR |
10.1124 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EGFR, ESR1, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, HSD17B3, MET, MIF, PPARA, PTGES |
9.89308 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AXL, CSNK2A1, CYP1B1, EGFR, ESRRA, F10, F3, FABP4, FLT3, GPER1, GPR35, GSK3B, HSPA1A, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP2, MMP9, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
9.89308 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA6, CA7, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TYR, XDH |
9.89308 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, ALOX15, ALPL, APP, AR, AXL, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, GPER1, GSK3B, HSPA1A, IGF1R, INSR, KCNH2, KDR, MMP2, MMP9, RELA, RORC, SLC6A4, SMAD3, SRC, TERT |
9.49815 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX15, ALPL, APP, AR, AURKB, AXL, CA2, CA6, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, F10, F3, FABP3, FABP4, FLT3, GPER1, GSK3B, HSD17B2, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MIF, MMP12, MMP2, MMP9, NUAK1, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TYR |
9.47569 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, ALPL, APP, AR, CA2, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, GPER1, GSK3B, IGF1R, INSR, MMP2, PPARA, RELA, SLC6A4, SMAD3, SRC, TEK |
9.26436 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GPER1, GPR35, GSK3B, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
9.24363 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, APP, AR, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, EGFR, F10, F3, GPER1, GPR35, GSK3B, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAP2K1, MET, MIF, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SMAD3, SRC, TEK, TERT |
9.04674 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ADRA2A, APP, CYP19A1, DUSP3, EGFR, ESR1, F3, FABP4, GPER1, GSK3B, HSPA1A, IGF1R, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP2, NUAK1, PPARA, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
8.91076 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA6, CA7, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP2, NUAK1, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TYR, XDH |
8.88613 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GPER1, GSK3B, HSPA1A, IGF1R, KDR, MAP2K1, MET, MIF, MMP9, PIM1, PPARA, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
8.55312 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GPER1, GSK3B, HSPA1A, IGF1R, KDR, MAP2K1, MET, MIF, MMP9, PIM1, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
8.55113 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, HSD17B3, INSR, KDR, MAP2K1, PPARA, RELA, SMAD3, SRC, TEK, TYR |
8.50531 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, ALOX15, ALPL, APP, AR, AURKB, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, GPER1, GSK3B, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MIF, MMP2, MMP9, NUAK1, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TERT |
8.40485 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, MAP3K7, PIM1, PPARA, RELA, RORC, SRC |
8.36609 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AR, AXL, CA2, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, GPER1, HSD17B2, PTGES, RELA, RORC, SLC6A4, SRC, TYR |
8.31859 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AR, AXL, CACNA1C, CYP19A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRB, F10, F3, FABP4, GPER1, HSD17B2, IGF1R, INSR, KCNH2, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, RELA, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TYR |
8.31859 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, AR, CA2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, ESRRA, FLT3, GPER1, PTGES, RELA, RORC, SLC6A4, SRC, TEK, TYR |
8.28961 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA6, CA7, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, FUT7, HSD17B3, HSPA1A, MIF, PIM1, PPARA, PTGES, TYR, XDH |
8.1777 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, ALPL, AR, CA2, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, GPER1, INSR, PPARA, RELA, SLC6A4, SRC, TEK |
8.08932 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, EGFR, GSK3B, HSPA1A, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PTPN1, RELA, SMAD3, SRC, TEK, TERT |
7.96946 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GPER1, GSK3B, HSPA1A, IGF1R, KDR, MAP2K1, MIF, MMP9, PIM1, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
7.96946 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA2A, ALOX15, APP, AR, EGFR, FLT3, GPER1, INSR, KDR, MAP2K1, MAP3K7, MIF, PTPN1, SRC, TEK, XDH |
7.95417 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, HSD17B1, HSD17B2, HSD17B3 |
7.94801 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F10, F3, FLT3, GPER1, GPR35, GSK3B, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, NUAK1, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
7.90902 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, APP, CYP19A1, CYP1B1, EGFR, F10, F3, GPER1, IGF1R, INSR, KDR, MET, MIF, MMP9, SMAD3, SRC, TEK, TERT |
7.90902 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, EGFR, GSK3B, HSPA1A, IGF1R, KDR, MET, MIF, MMP9, PIM1, PTPN1, RELA, SMAD3, SRC, TEK, TERT |
7.89798 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, AR, CDC25B, CSNK2A1, EGFR, ESR1, F3, FLT3, GPER1, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, PIM1, RELA, TEK, TERT |
7.76012 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, APP, CACNA1C, CYP19A1, CYP1B1, EGFR, F10, F3, GPER1, IGF1R, INSR, KDR, MET, MIF, MMP9, SMAD3, SRC, TEK, TERT |
7.6878 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MMP9, PTGES, RELA, SRC, TERT |
7.67128 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, ALOX15, ALPL, APP, AR, AXL, CYP1A1, CYP1B1, EGFR, ESR1, FABP4, FLT3, GPER1, GSK3B, IGF1R, INSR, KDR, MMP2, RELA, RORC, SLC6A4, SMAD3, SRC |
7.65097 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA2A, ALOX15, APP, AR, DUSP3, EGFR, FLT3, GPER1, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MIF, PTPN1, SRC, TEK, XDH |
7.59071 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, F10, F3, FABP4, FLT3, GPER1, GPR35, GSK3B, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP2, MMP9, NUAK1, PPARA, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
7.51211 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, APP, CYP19A1, CYP1B1, EGFR, F10, F3, GPER1, IGF1R, INSR, KDR, MET, MIF, MMP9, SMAD3, SRC, TEK, TERT |
7.49401 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, AURKB, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, GSK3B, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PPARA, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
7.4233 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, AURKB, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, GSK3B, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TERT, XDH |
7.29992 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA2A, AR, DUSP3, EGFR, ESR1, ESR2, GPER1, GPR35, GSK3B, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PTPN1, RELA, SLC6A4, SMAD3, SRC, TERT, XDH |
7.2474 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, EGFR, GSK3B, HSPA1A, IGF1R, KDR, MIF, MMP9, PIM1, PTPN1, RELA, SMAD3, SRC, TEK, TERT |
7.2474 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA2A, AR, DUSP3, EGFR, ESR1, ESR2, GPER1, GPR35, GSK3B, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PTPN1, RELA, SLC6A4, SMAD3, SRC, TERT, XDH |
7.23168 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, AURKB, CDC25B, CSNK2A1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GPER1, GSK3B, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PPARA, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
7.20908 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, MIF, PTGES |
7.1305 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, APP, EGFR, F10, F3, GPER1, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TERT |
7.0277 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA2A, APP, AR, AXL, CA2, CACNA1C, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, F3, GPER1, GPR35, GSK3B, HSPA1A, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PIM1, RELA, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
6.98728 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, APP, CYP19A1, CYP1B1, EGFR, F10, F3, GPER1, IGF1R, INSR, KDR, MET, MIF, MMP9, SMAD3, SRC, TEK, TERT |
6.98728 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, EGFR, ESRRB, FABP3, FLT3, GPER1, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
6.98728 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, EGFR, ESRRB, FABP3, FLT3, GPER1, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
6.98728 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, AURKB, CDC25B, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GPER1, GSK3B, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TERT, XDH |
6.91738 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, MIF, PTGES |
6.90235 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APP, AR, AURKB, AXL, CA2, CACNA1C, CDC25B, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GSK3B, HSD17B2, HSD17B3, INSR, KDR, MAP2K1, MET, MIF, MMP2, MMP9, PIM1, PPARA, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TYR |
6.89542 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KDR, PIM1, SRC, TEK |
6.87692 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, APP, EGFR, F10, F3, GPER1, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TERT |
6.87149 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, GPER1, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
6.84824 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
6.84824 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA2A, ALOX15, AR, CYP19A1, DUSP3, EGFR, ESR1, ESR2, GPER1, GSK3B, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
6.82465 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA2A, APP, AR, AURKB, CDC25B, EGFR, ESR1, ESR2, F3, FLT3, GPER1, GSK3B, HSPA1A, INSR, MAP2K1, MAP3K7, MET, MIF, MMP9, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
6.82413 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, CSNK2A1, EGFR, ESR1, F3, FLT3, GPER1, GSK3B, HSPA1A, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, RELA, SMAD3, SRC, TEK, XDH |
6.79828 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, GPER1, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
6.7965 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, APP, EGFR, F10, F3, GPER1, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TERT |
6.74937 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TERT, TYR, XDH |
6.61345 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, APP, EGFR, F10, F3, GPER1, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TERT |
6.55925 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPER1, GPR35, GSK3B, HSPA1A, IGF1R, KCNH2, KDR, MAP2K1, MET, MIF, MMP12, MMP9, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
6.45235 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA2A, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, FLT3, GPER1, GPR35, GSK3B, HSPA1A, IGF1R, INSR, MAP2K1, MAP3K7, MET, MIF, MMP9, NUAK1, PIM1, PPARA, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
6.45235 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APP, AR, AXL, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FLT3, GSK3B, HSD17B2, HSD17B3, INSR, KDR, MAP2K1, MMP9, PIM1, PPARA, RELA, RORC, SMAD3, SRC, TEK, TYR |
6.35559 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, EGFR, ESRRB, FLT3, GPER1, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SRC, TEK, XDH |
6.31726 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ADRA2A, ALOX15, APP, AXL, CA2, CA7, CACNA1C, CYP19A1, EGFR, GPER1, GPR35, GSK3B, HSPA1A, INSR, KCNH2, MAP2K1, MIF, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SMAD3, SRC, TERT |
6.29969 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GSK3B, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TERT, TYR, XDH |
6.28814 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA2A, APP, AR, AURKB, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, GPER1, GSK3B, HSPA1A, IGF1R, INSR, MAP2K1, MAP3K7, MIF, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
6.25202 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, MIF, PPARA, PTGES |
6.20897 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC, SRC |
6.18162 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, DUSP3, EGFR, ESRRB, FABP4, FLT3, GPER1, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP9, PPARA, PTPN1, SRC, TEK, XDH |
6.08851 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MET, SRC, TEK |
6.02691 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MET, SRC, TEK |
5.96423 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
5.96089 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, EGFR, ESR1, F3, FLT3, GPER1, GSK3B, HSPA1A, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
5.95358 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA2A, APP, AR, AXL, CA2, CYP1B1, EGFR, ESRRB, F3, GPER1, HSPA1A, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, PIM1, RELA, SMAD3, SRC, TEK, TERT |
5.94106 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, EGFR, FLT3, GPER1, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SRC, TEK, XDH |
5.89845 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA6, CA7 |
5.858 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPER1, GPR35, GSK3B, HSPA1A, IGF1R, KCNH2, KDR, MAP2K1, MET, MIF, MMP12, MMP9, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
5.82077 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CYP1B1, EGFR, ESR1, GPER1, GSK3B, IGF1R, INSR, MMP2, MMP9, RELA, RORC, SLC6A4, SRC |
5.79615 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, ALOX5, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EGFR, FABP3, FABP4, FUT7, MET, MIF, PPARA, PTGES |
5.78206 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, ADRA2A, DUSP3, EGFR, FLT3, IGF1R, INSR, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
5.60964 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2, HSD17B3 |
5.59011 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, APP, AR, EGFR, ESR1, FLT3, GPER1, GSK3B, IGF1R, INSR, MMP2, RELA, SLC6A4, SMAD3, SRC |
5.59011 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, MIF, PTGES |
5.59011 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, EGFR, F10, F3, GPER1, INSR, MET, SRC, TEK, XDH |
5.57667 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DUSP3, EGFR, GPER1, KDR, MAP2K1, MIF, PTPN1, SRC, TEK |
5.57628 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA2A, AKR1B1, APP, AXL, CA12, CA2, CA7, CACNA1C, EGFR, ESR1, FABP3, FABP4, FLT3, GPER1, GPR35, INSR, KCNH2, MET, SMAD3, SRC, TERT |
5.54759 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, GPER1, HSD17B1, HSD17B2, HSD17B3 |
5.52452 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, AR, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, GPER1, RORC, SLC6A4, SRC |
5.49614 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, DUSP3, EGFR, FABP4, FLT3, GPER1, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP9, NUAK1, PTPN1, RELA, SRC, TEK, XDH |
5.49407 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, DUSP3, EGFR, FABP4, FLT3, GPER1, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SRC, TEK, XDH |
5.46342 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC, SRC |
5.35359 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, PTPN1, SRC, TEK, XDH |
5.27904 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APP, AURKB, CDC25B, CYP1A1, DUSP3, EGFR, GPER1, INSR, MIF, SLC6A4, SRC, TERT |
5.25446 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA2A, APP, AURKB, CDC25B, EGFR, ESR1, F3, FLT3, GPER1, GSK3B, HSPA1A, INSR, MAP2K1, MAP3K7, MIF, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
5.25003 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA2A, AR, DUSP3, EGFR, ESR1, ESR2, GPER1, GSK3B, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PTPN1, RELA, SMAD3, SRC, TERT, XDH |
5.17632 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, ADRA2A, APP, AXL, CA2, CYP19A1, EGFR, GPER1, GSK3B, INSR, KCNH2, MIF, MMP12, SLC6A4, SMAD3, SRC, TERT |
5.10029 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
5.07745 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, TYR |
5.02991 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, EGFR, FABP3, FLT3, GPER1, GSK3B, IGF1R, INSR, MMP2, PPARA, RELA, SLC6A4, SRC, TEK, TYR |
5.01795 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2, HSD17B3 |
5.0047 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, PTPN1, SRC, TEK, XDH |
4.90988 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGES |
4.8898 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, EGFR, ESR1, F3, FABP4, GPER1, KDR, MAP2K1, MET, MIF, MMP12, PPARA, RELA, SMAD3, TEK |
4.85512 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, GPER1, GSK3B, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP9, NUAK1, PTPN1, RELA, SMAD3, SRC, TEK, XDH |
4.85512 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, GPER1, HSPA1A, MAP3K7, MMP12, MMP2, PPARA, PTPN1, RELA, SMAD3, SRC, TEK |
4.83046 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, GSK3B, HSD17B1, HSD17B2, HSD17B3, MAOA, TYR, XDH |
4.83046 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, ADRA2A, APP, AURKB, CDC25B, DUSP3, EGFR, FABP4, FLT3, GSK3B, IGF1R, INSR, MAP2K1, MAP3K7, MIF, PTPN1, SRC, TEK |
4.7975 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, EGFR, GPER1, KDR, MAP2K1, MIF, SRC, TEK |
4.7975 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, ADRA2A, EGFR, FLT3, INSR, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
4.76223 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA2A, AKR1B1, APP, AR, AXL, CA1, CA2, CACNA1C, CSNK2A1, CYP1B1, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, GPR35, GSK3B, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MIF, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SMAD3, SRC, TEK |
4.75903 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
4.69585 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, FABP4, FUT7, GSK3B, HSPA1A, MAOA, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
4.63259 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, GPER1, GSK3B, IGF1R, INSR, PPARA, RELA, SRC, TEK |
4.62047 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, EGFR, FABP3, FLT3, GPER1, GSK3B, IGF1R, INSR, MMP2, PPARA, RELA, SLC6A4, SRC, TEK, TYR |
4.61101 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AR, AURKB, AXL, ESR1, GPER1, GSK3B, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MET, MMP1, MMP9, SMAD3, SRC, TEK |
4.59974 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, F10, F3, INSR, MET, SRC, TEK |
4.56783 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA2A, AKR1B1, APP, CA12, CA2, CA7, CACNA1C, EGFR, ESR1, FABP3, FABP4, GPER1, GPR35, INSR, KCNH2, MET, SMAD3 |
4.53862 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, GPER1, GSK3B, HSPA1A, MAP2K1, MAP3K7, MIF, MMP2, MMP9, NUAK1, PPARA, PTGES, PTPN1, RELA, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT |
4.53862 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, ADRA2A, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, MAP2K1, MAP3K7, MIF, PTPN1, SRC, TEK |
4.43381 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, RELA, SRC |
4.41902 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, EGFR, FLT3, GPER1, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP9, PTPN1, SRC, TEK, XDH |
4.41575 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AR, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, DUSP3, EGFR, ESR1, F10, F3, FLT3, FUT7, GSK3B, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RELA, SMAD3, SRC, TEK, TYR, XDH |
4.3593 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DUSP3, EGFR, GSK3B, HSPA1A, IGF1R, MAP2K1, MAP3K7, MET, MIF, NUAK1, PTPN1, TERT, XDH |
4.35758 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, CYP1A1, EGFR, ESR1, FLT3, MAP2K1, MET, MIF, PIM1, SRC, TEK, TYR |
4.32258 |
[BP] GO:2001233 |
regulation of apoptotic signaling pathway
|
AR, GPER1, GSK3B, HSPA1A, MIF, MMP9, PTPN1, RELA, SMAD3, SRC, TERT |
4.28298 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, RORC |
4.27637 |
[BP] GO:0070920 |
None
|
EGFR, ESR1, MAP2K1, TERT |
4.24773 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, EGFR, HSPA1A, MMP2, PPARA, RELA, SLC6A4, SMAD3, SRC, TEK, TERT, TYR |
4.20782 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, MIF, PPARA, PTGES |
4.18149 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MAP3K7, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
4.18071 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA2A, AKR1B1, AXL, CACNA1C, CYP1B1, EGFR, GPER1, GSK3B, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MIF, NUAK1, PTPN1, RELA, SRC, TEK |
4.16513 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, ADRA2A, ALOX15, APP, AR, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, GPER1, GSK3B, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MIF, MMP9, NUAK1, PTPN1, RELA, SMAD3, SRC, TEK, XDH |
4.16153 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA6, CA7, CACNA1C, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GPER1, GPR35, GSK3B, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TYR, XDH |
4.15018 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, EGFR, GPER1, GSK3B, IGF1R, INSR, MMP2, RELA, SLC6A4, SRC |
4.15018 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, APP, AR, AURKB, CSNK2A1, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, GPER1, GSK3B, HSPA1A, IGF1R, KDR, MAP2K1, MET, MIF, MMP12, MMP9, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TERT, XDH |
4.13955 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, ADRA2A, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
4.13069 |
[BP] GO:0048732 |
gland development
|
AR, CSNK2A1, CYP19A1, EGFR, INSR, MAP2K1, RELA, SMAD3, TYR |
4.13043 |
[BP] GO:0010675 |
None
|
ESRRB, GPER1, GSK3B, INSR, PPARA, RORC, SRC |
4.12929 |
[BP] GO:0050793 |
regulation of developmental process
|
APP, AR, AXL, CA2, CYP1B1, EGFR, ESR1, ESRRA, ESRRB, F3, GPER1, GSK3B, INSR, KDR, MAP2K1, MIF, NUAK1, PIM1, PPARA, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
4.10551 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, APP, CA2, CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGES, TERT |
4.10006 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, PTGES, RELA, SLC6A4, SRC |
4.06538 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SRC, TEK |
4.02716 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, APP, AURKB, CSNK2A1, CYP1B1, DUSP3, ESR1, FABP4, GPR35, GSK3B, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
4.01402 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AR, AXL, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, HSD17B3, INSR, MAP2K1, SRC |
4.00041 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, AR, CYP1B1, FABP3, GPER1, HSPA1A, MAP2K1, PTGES, SLC6A4, SMAD3, TERT, XDH |
4.00041 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, DUSP3, EGFR, FLT3, IGF1R, INSR, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
3.99974 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, APP, CES1, CYP19A1, CYP1A1, CYP1B1, HSD17B3, MAOA, TYR |
3.98203 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AR, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSPA1A, IGF1R, INSR, MAP2K1, MET, MMP12, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TERT |
3.97122 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, EGFR, GPER1, INSR, MAOA, SLC6A2, SLC6A4, SMAD3 |
3.97054 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, MMP2, PPARA, SLC6A4, SMAD3, SRC, TEK, TERT |
3.91879 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
DUSP3, ESR1, GPER1, HSPA1A, IGF1R, MET, MIF, MMP9, PTPN1, RELA, SRC, XDH |
3.88803 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, RELA, SRC |
3.86545 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, EGFR, GPER1, GSK3B, IGF1R, INSR, MMP2, RELA, SLC6A4, SRC |
3.85845 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.84354 |
[BP] GO:0042058 |
None
|
ADORA1, ADRA2A, APP, EGFR, GPER1, MMP9 |
3.83228 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, SLC6A4, SMAD3, SRC, TEK, TERT |
3.82646 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.81459 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, CYP19A1, ESR1, HSD17B2, HSD17B3, INSR, MAP2K1, SRC |
3.79055 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, EGFR, FLT3, INSR, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
3.77251 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AR, AXL, CDC25B, CYP19A1, CYP1A1, EGFR, ESR1, ESRRB, HSD17B2, HSD17B3, INSR, MAP2K1, MMP2, MMP9, SLC6A4, SRC |
3.76165 |
[BP] GO:0071396 |
cellular response to lipid
|
AR, AXL, EGFR, ESR1, FLT3, GPER1, RELA, RORC, SLC6A4, SRC |
3.72352 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, GSK3B, MET, MMP9, PPARA, SRC, TERT |
3.71097 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APP, GPER1, GSK3B, IGF1R, INSR, RELA, SRC |
3.6659 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, ADRA2A, CDC25B, EGFR, FLT3, INSR, MAP2K1, MAP3K7, MIF, PTPN1, SRC, TEK |
3.66181 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AR, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, GPER1, IGF1R, INSR, KDR, MAP2K1, MET, MMP12, PPARA, RELA, RORC, SMAD3, SRC, TERT |
3.66181 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AR, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, GPER1, IGF1R, INSR, KDR, MAP2K1, MET, MMP12, PPARA, RELA, RORC, SMAD3, SRC, TERT |
3.66181 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, CYP1A1, FABP3, FLT3, GPER1, PPARA, RORC, SRC, TEK |
3.66181 |
[BP] GO:0010676 |
None
|
ESRRB, GPER1, INSR, PPARA, SRC |
3.65608 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, EGFR, F10, FLT3, GSK3B, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, SRC, TEK |
3.638 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, EGFR, ESR1, GSK3B, PPARA, RORC, SLC6A4, SRC |
3.638 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, HSPA1A, MIF, MMP9, PTPN1, RELA, SRC, TERT |
3.6373 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CES1, CSNK2A1, CYP19A1, CYP1A1, HSD17B1, HSD17B2, HSD17B3, MIF, PTGES |
3.63533 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.60712 |
[BP] GO:0010906 |
None
|
ESRRB, GSK3B, INSR, PPARA, RORC, SRC |
3.59535 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
APP, DUSP3, EGFR, IGF1R, MAP2K1, MAP3K7, PTPN1, XDH |
3.58618 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
APP, DUSP3, EGFR, IGF1R, MAP2K1, MAP3K7, PTPN1, XDH |
3.5731 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, SLC6A4, SMAD3, SRC, TEK, TERT |
3.56669 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, AR, CA2, EGFR, FLT3, GPER1, RELA, SRC |
3.5324 |
[BP] GO:1901184 |
None
|
ADORA1, ADRA2A, APP, EGFR, GPER1, MMP9 |
3.52662 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, CA1, CSNK2A1, EGFR, F3, FLT3, GPR35, GSK3B, IGF1R, INSR, KDR, MAP3K7, MET, MIF, MMP2, MMP9, PTPN1, RELA, SMAD3, SRC, TEK |
3.51203 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA2A, EGFR, GPER1, SLC6A4, SRC, TEK |
3.51098 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2C19, PTGES |
3.50669 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, CA2, CA7, CACNA1C, EGFR, GPER1, KDR, MIF, SRC |
3.4887 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.46491 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, ADRA2A, AURKB, CDC25B, EGFR, FLT3, INSR, MAP2K1, MAP3K7, MIF, PTPN1, SRC, TEK |
3.45598 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, ADRA2A, CSNK2A1, EGFR, ESRRB, GSK3B, HSPA1A, INSR, KDR, MAP3K7, MET, PPARA, PTPN1, RELA, SMAD3 |
3.45594 |
[BP] GO:0051726 |
regulation of cell cycle
|
APP, AURKB, CDC25B, CSNK2A1, CYP1A1, DUSP3, EGFR, GPER1, HSPA1A, INSR, MAP2K1, MIF, PIM1, SLC6A4, SMAD3, SRC, TERT |
3.45182 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
ADORA3, APP, AR, CYP1B1, ESR1, ESR2, HSPA1A, MAP3K7, PIM1, RELA |
3.45113 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, GPER1, PPARA, RELA, SMAD3, TEK |
3.45113 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
3.43945 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APP, AR, AURKB, CSNK2A1, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, GPER1, GSK3B, HSPA1A, IGF1R, KDR, MAP2K1, MIF, MMP12, MMP9, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TERT, XDH |
3.42998 |
[BP] GO:0050730 |
None
|
ADORA1, ADRA2A, APP, EGFR, FLT3, MIF, PTPN1, SRC |
3.39002 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, ADRA2A, APP, CA2, CACNA1C, EGFR, GPER1, GSK3B, MIF, MMP12, PTPN1, SMAD3, SRC |
3.37417 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2, HSD17B3 |
3.36418 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
APP, AR, AXL, CA2, CYP1B1, EGFR, ESR1, ESRRA, F3, GPER1, GSK3B, INSR, KDR, MAP2K1, PIM1, RELA, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
3.36418 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EGFR |
3.36418 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, CES1, CYP1A1, CYP1B1, KDR, RELA, SLC6A4, SRC |
3.33093 |
[BP] GO:0051254 |
None
|
APP, AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSPA1A, INSR, MAP2K1, MET, MMP12, PPARA, RELA, RORC, SMAD3, SRC, TERT |
3.27712 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, GPER1, MMP12, PPARA, SMAD3, TEK |
3.26637 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, ADRA2A, APP, CA2, CA7, CACNA1C, GPER1, GPR35, KCNH2, MIF, MMP9, SLC6A4 |
3.26479 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AR, AURKB, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, GPER1, IGF1R, INSR, MAP2K1, MET, MMP12, PPARA, RELA, RORC, SMAD3, SRC, TERT |
3.26479 |
[BP] GO:0006109 |
regulation of carbohydrate metabolic process
|
ESRRB, GPER1, GSK3B, INSR, PPARA, RORC, SRC |
3.22352 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, RELA, SRC |
3.22352 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, GPER1, GSK3B, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
3.22187 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, EGFR, MMP2, MMP9, TEK |
3.22187 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, APP, AR, AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, F10, F3, FLT3, FUT7, GSK3B, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RELA, SMAD3, SRC, TEK |
3.22001 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, ADRA2A, CDC25B, EGFR, FLT3, INSR, MAP2K1, MAP3K7, MIF, PTPN1, SRC |
3.2099 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, GPER1, PPARA, SMAD3, TEK |
3.20493 |
[BP] GO:0045913 |
None
|
ESRRB, GPER1, INSR, PPARA, SRC |
3.15517 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, CYP1A1, EGFR, PPARA, SMAD3 |
3.15447 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GPER1, GSK3B, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, NUAK1, PIM1, PPARA, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
3.14347 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPER1, GSK3B, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, NUAK1, PIM1, PPARA, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
3.14347 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, MIF, PIM1, PPARA, PTGES, TYR |
3.13118 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ALOX15, APP, AXL, CA2, CYP19A1, DUSP3, ESR1, ESRRA, GPER1, HSPA1A, MAP3K7, MIF, MMP12, MMP2, PTPN1, RELA, SMAD3, SRC |
3.11509 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EGFR, HSPA1A, MAOA |
3.11509 |
[BP] GO:1902893 |
None
|
PPARA, RELA, SMAD3, TERT |
3.11509 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
3.11509 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, APP, AR, AXL, CDC25B, CES1, CYP1A1, EGFR, ESR1, ESRRB, FABP4, FLT3, FUT7, GSK3B, KDR, MAP2K1, MET, MIF, MMP2, MMP9, RORC, SMAD3, SRC, TEK, TERT |
3.10691 |
[BP] GO:0010628 |
positive regulation of gene expression
|
APP, AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, GPER1, GSK3B, HSPA1A, INSR, MAP2K1, MET, MMP12, PPARA, RELA, RORC, SLC6A4, SMAD3, SRC, TERT |
3.0971 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, EGFR, GPER1 |
3.0971 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
3.08345 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, CYP1B1, EGFR, HSPA1A, MMP9, RELA, SRC |
3.07766 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, GSK3B, MET, MMP9, PPARA, SMAD3, SRC, TERT |
3.07766 |
[BP] GO:0032870 |
cellular response to hormone stimulus
|
ADRA2A, AR, EGFR, ESR1, FLT3, GPER1, INSR, RELA, SRC |
3.07766 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, APP, AR, AURKB, CSNK2A1, DUSP3, ESR1, ESR2, ESRRA, FABP4, GPER1, GSK3B, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TERT, XDH |
3.06729 |
[BP] GO:0051094 |
positive regulation of developmental process
|
APP, AR, AXL, CA2, CYP1B1, ESRRB, F3, GPER1, INSR, KDR, MAP2K1, PIM1, RELA, SMAD3, SRC, TEK, TERT |
3.06729 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, EGFR, ESR1, ESRRA, GPER1, SLC6A4 |
3.04999 |
[BP] GO:0051172 |
None
|
ADRA2A, APP, AR, AURKB, CSNK2A1, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, GPER1, HSPA1A, IGF1R, MIF, MMP12, MMP9, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TERT, XDH |
3.04494 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EGFR |
3.03544 |
[BP] GO:0045893 |
None
|
APP, AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, GPER1, INSR, MAP2K1, MET, MMP12, PPARA, RELA, RORC, SMAD3, SRC, TERT |
3.03544 |
[BP] GO:1903508 |
None
|
APP, AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, GPER1, INSR, MAP2K1, MET, MMP12, PPARA, RELA, RORC, SMAD3, SRC, TERT |
3.03544 |
[BP] GO:1902680 |
None
|
APP, AR, EGFR, ESR1, ESR2, ESRRA, ESRRB, GPER1, INSR, MAP2K1, MET, MMP12, PPARA, RELA, RORC, SMAD3, SRC, TERT |
3.03422 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CES1, CYP19A1, HSD17B1, HSD17B2, HSD17B3 |
3.02219 |
[BP] GO:0071383 |
None
|
AR, EGFR, FLT3, GPER1, SRC |
3.01923 |
[BP] GO:0009896 |
positive regulation of catabolic process
|
ADRA2A, CSNK2A1, ESRRB, GSK3B, HSPA1A, INSR, KDR, MAP3K7, PPARA, PTPN1 |
3.01223 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, GPER1, MMP2, MMP9, TERT |
2.98898 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APP, AURKB, CDC25B, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, MAP2K1, PIM1, SMAD3, TERT |
2.97944 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, TERT |
2.96976 |
[BP] GO:0045742 |
None
|
ADORA1, ADRA2A, GPER1, MMP9 |
2.95612 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX15, ALOX5, MIF, PTGES |
2.95612 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, ADRA2A, APP, AR, CACNA1C, CSNK2A1, EGFR, GPER1, GSK3B, MIF, MMP12, PTPN1, SMAD3, SRC, TERT |
2.945 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.93127 |
[BP] GO:0050801 |
ion homeostasis
|
APP, CA12, CA2, CA7, CACNA1C, EGFR, ESR1, FABP3, GPER1, GPR35, KCNH2, SMAD3 |
2.92601 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, GPER1, SRC |
2.92599 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA2A, ALOX15, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPER1, GSK3B, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, NUAK1, PIM1, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TERT, XDH |
2.92561 |
[BP] GO:0048806 |
genitalia development
|
AXL, CYP19A1, ESR1, HSD17B3 |
2.91905 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.89413 |
[BP] GO:1901186 |
None
|
ADORA1, ADRA2A, GPER1, MMP9 |
2.87757 |
[BP] GO:1904705 |
regulation of vascular smooth muscle cell proliferation
|
GPER1, MMP2, MMP9, TERT |
2.87757 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, EGFR, KCNH2, KDR, RELA, SRC |
2.86188 |
[BP] GO:0043255 |
regulation of carbohydrate biosynthetic process
|
ESRRB, GPER1, GSK3B, INSR, PPARA |
2.85577 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.84668 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA2A, EGFR, GPER1, SLC6A4, SRC, TEK |
2.84668 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, GPER1, MMP9, SMAD3, SRC, XDH |
2.838 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, EGFR, RELA, TYR |
2.838 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, CACNA1C, GPER1, KDR, SRC |
2.81556 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.80974 |
[BP] GO:0010629 |
None
|
APP, AR, AURKB, ESR1, ESR2, ESRRA, FABP4, GPER1, HSPA1A, KDR, MAP2K1, MIF, MMP12, PPARA, RELA, RORC, SMAD3, SRC, TERT, XDH |
2.80862 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ADRA2A, ALOX15, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPER1, GSK3B, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, NUAK1, PIM1, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TERT, XDH |
2.78096 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, EGFR, GPER1, MIF, MMP12, SLC6A4, SRC |
2.77145 |
[BP] GO:1901224 |
None
|
APP, EGFR, MAP3K7, RELA |
2.7707 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APP, CDC25B, CYP1A1, DUSP3, INSR, TERT |
2.7494 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX15, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, MIF, PIM1, PPARA, PTGES, TYR |
2.74352 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ALOX15, ESR1, GSK3B, HSPA1A, KDR, MET, MMP1, SMAD3, SRC, TEK |
2.74026 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.74002 |
[BP] GO:1903798 |
None
|
EGFR, ESR1, MAP2K1 |
2.73237 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPER1, GSK3B, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MIF, MMP12, MMP9, NUAK1, PIM1, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TERT, XDH |
2.72041 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, EGFR, GPER1, SLC6A4 |
2.6991 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, EGFR, GPER1, SLC6A4 |
2.6991 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.6951 |
[BP] GO:0001819 |
positive regulation of cytokine production
|
ADRA2A, CYP1B1, HSPA1A, MAP3K7, MIF, MMP12, RELA, SMAD3, SRC |
2.68343 |
[BP] GO:0031331 |
positive regulation of cellular catabolic process
|
ADRA2A, ESRRB, GSK3B, HSPA1A, INSR, KDR, MAP3K7, PPARA, PTPN1 |
2.68343 |
[BP] GO:0045862 |
positive regulation of proteolysis
|
ADRA2A, APP, F3, GPER1, GSK3B, HSPA1A, SMAD3, SRC, XDH |
2.68343 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX15, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2C19, FABP3, MIF, PIM1, PPARA, PTGES, TYR |
2.67599 |
[BP] GO:0001954 |
positive regulation of cell-matrix adhesion
|
GSK3B, KDR, SMAD3, TEK |
2.67599 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.65854 |
[BP] GO:0031334 |
positive regulation of protein complex assembly
|
ALOX15, ESR1, GSK3B, HSPA1A, MET, MMP1, SRC |
2.63332 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX15, APP, AR, AURKB, AXL, CSNK2A1, EGFR, ESR1, ESR2, GPER1, GSK3B, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MET, MMP1, MMP9, PTPN1, SMAD3, SRC, TEK |
2.63302 |
[BP] GO:2001236 |
regulation of extrinsic apoptotic signaling pathway
|
AR, GPER1, HSPA1A, RELA, SRC, TERT |
2.59485 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, CYP1A1, CYP1B1, EGFR, FABP3, KCNH2, KDR, RELA, SLC6A2, SLC6A4, SRC |
2.58505 |
[BP] GO:0032147 |
activation of protein kinase activity
|
ADORA1, ADRA2A, EGFR, INSR, MAP2K1, MAP3K7, PTPN1, SRC |
2.58505 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
HSPA1A, MIF, MMP9, PTPN1, SRC |
2.57617 |
[BP] GO:2000351 |
None
|
GPER1, KDR, TEK, TERT |
2.54067 |
[BP] GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling
|
EGFR, FLT3, GPER1, KDR, TEK |
2.53633 |
[BP] GO:0033590 |
None
|
EGFR, RELA |
2.53401 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.53401 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.53401 |
[BP] GO:0002520 |
None
|
CACNA1C, SMAD3 |
2.53401 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, F3, GPER1, MMP9, SMAD3, SRC, XDH |
2.52111 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7, FABP3, PPARA |
2.51815 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX15, CES1, CYP19A1, HSD17B3, TYR |
2.50564 |
[BP] GO:0000904 |
cell morphogenesis involved in differentiation
|
AR, AXL, MET, SRC, TEK |
2.48479 |
[BP] GO:0060341 |
regulation of cellular localization
|
ADRA2A, APP, AR, CACNA1C, CSNK2A1, EGFR, GPER1, GSK3B, MAP2K1, PTPN1, SMAD3, SRC, TERT |
2.4756 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA7, CACNA1C, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GPER1, GPR35, GSK3B, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
2.47222 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.47222 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.47222 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.47222 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.47222 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
APP, CA12, CA2, CA7, CACNA1C, EGFR, ESR1, GPER1, GPR35, KCNH2, SMAD3 |
2.47066 |
[BP] GO:0050678 |
None
|
AR, EGFR, F3, KDR, MMP12, SMAD3, TEK, XDH |
2.46027 |
[BP] GO:0051091 |
positive regulation of DNA binding transcription factor activity
|
APP, AR, ESR1, ESR2, HSPA1A, MAP3K7, RELA |
2.45607 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
GSK3B, KDR, SMAD3, SRC, TEK |
2.43836 |
[BP] GO:2001237 |
negative regulation of extrinsic apoptotic signaling pathway
|
AR, HSPA1A, RELA, SRC, TERT |
2.43836 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
APP, EGFR, INSR, KDR, RELA, SMAD3, SRC |
2.43819 |
[BP] GO:0046328 |
regulation of JNK cascade
|
APP, DUSP3, EGFR, IGF1R, MAP3K7, PTPN1 |
2.42187 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.40589 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.40589 |
[BP] GO:0010811 |
positive regulation of cell-substrate adhesion
|
ALOX15, GSK3B, KDR, SMAD3, TEK |
2.38787 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.38733 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX15, ALOX5, CES1, CYP19A1, CYP1A1, HSD17B3, MIF, PTGES |
2.38416 |
[BP] GO:0009653 |
anatomical structure morphogenesis
|
APP, AR, AXL, CA2, CACNA1C, CYP1B1, EGFR, ESR1, INSR, MET, MMP2, RELA, SLC6A4, SMAD3, SRC, TEK |
2.37861 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, ADRA2A, FLT3, MIF, PTPN1, SRC |
2.37779 |
[BP] GO:0051223 |
None
|
ACHE, ADRA2A, APP, CACNA1C, EGFR, GPER1, GSK3B, MIF, MMP12, PTPN1, SMAD3, SRC |
2.375 |
[BP] GO:0006464 |
cellular protein modification process
|
ALPL, APP, AR, AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, GSK3B, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK |
2.36911 |
[BP] GO:0036211 |
protein modification process
|
ALPL, APP, AR, AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, GSK3B, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK |
2.36911 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, RELA, SRC |
2.36125 |
[BP] GO:0046686 |
response to cadmium ion
|
CYP1A2, EGFR, MMP9, TERT |
2.36111 |
[BP] GO:0044267 |
cellular protein metabolic process
|
ALPL, APP, AR, AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, F10, FLT3, FUT7, GSK3B, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP2, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK |
2.36098 |
[BP] GO:0050679 |
None
|
AR, EGFR, F3, KDR, MMP12, TEK |
2.36098 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
CYP1B1, F3, GPER1, KDR, TEK, TERT |
2.36098 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, EGFR, GPER1, MIF, MMP12, SRC |
2.35438 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX15, CYP1B1, DUSP3, GSK3B, KDR, MAP3K7, NUAK1, PPARA, SMAD3, SRC, TEK |
2.34408 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.33724 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CSNK2A1, EGFR, RELA, SRC |
2.32449 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, ADRA2A, CACNA1C, EGFR, GPER1, MIF, MMP12, SRC |
2.30584 |
[BP] GO:1902895 |
None
|
RELA, SMAD3, TERT |
2.29944 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.29944 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.29944 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.29463 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.29463 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.29463 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, ADRA2A, EGFR, MET, PPARA, RELA, SMAD3 |
2.28837 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, ADRA2A, CACNA1C, CYP19A1, EGFR, GPER1, MIF, MMP12, SLC6A4, SRC |
2.28792 |
[BP] GO:0050920 |
regulation of chemotaxis
|
CYP19A1, F3, KDR, MET, MIF, SMAD3 |
2.28792 |
[BP] GO:1903532 |
None
|
ACHE, CYP19A1, EGFR, GPER1, MIF, MMP12, SLC6A4, SRC |
2.28256 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.25541 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, RELA |
2.24433 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.22759 |
[BP] GO:1901222 |
None
|
APP, EGFR, MAP3K7, RELA |
2.22169 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
ALOX15, GSK3B, KDR, SMAD3, SRC, TEK |
2.22167 |
[BP] GO:0033554 |
cellular response to stress
|
AKR1B1, ALOX15, AXL, CA2, CYP1B1, EGFR, GSK3B, HSPA1A, MAP2K1, MAP3K7, MIF, MMP9, NUAK1, PTPN1, RELA, SRC, TERT |
2.2147 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.20964 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.20964 |
[BP] GO:0070201 |
None
|
ACHE, ADRA2A, APP, CACNA1C, EGFR, GPER1, GSK3B, MIF, MMP12, PTPN1, SMAD3, SRC |
2.20627 |
[BP] GO:0001775 |
cell activation
|
ADRA2A, ALOX5, APP, AXL, EGFR, FLT3, FUT7, HSPA1A, MIF, MMP9, RORC, SMAD3, SRC |
2.18884 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, AXL, CYP1B1, KDR, RELA |
2.18884 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CYP1A1, CYP1A2, PTGES, RELA, SRC |
2.1706 |
[BP] GO:0007584 |
response to nutrient
|
ALPL, CYP1A1, EGFR, RELA, SLC6A4, TYR |
2.16916 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.16384 |
[BP] GO:0043434 |
None
|
FABP3, GPER1, INSR, PPARA, RELA, SRC, TEK |
2.16384 |
[BP] GO:0034097 |
response to cytokine
|
ALOX15, AXL, FABP4, FLT3, GPER1, GSK3B, PTGES, RELA, SRC |
2.1617 |
[BP] GO:0045595 |
regulation of cell differentiation
|
APP, AR, AXL, CA2, EGFR, ESRRA, ESRRB, GPER1, GSK3B, KDR, MAP2K1, PPARA, RELA, RORC, SLC6A4, SMAD3, TERT, XDH |
2.1617 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.16091 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, GPER1, MIF, PPARA, SMAD3, TEK |
2.16091 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
EGFR, F3, FABP4, KDR, MET, MIF, SMAD3 |
2.16091 |
[BP] GO:0070848 |
response to growth factor
|
APP, EGFR, INSR, KDR, RELA, SMAD3, SRC |
2.16091 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, SRC, TEK |
2.14996 |
[BP] GO:0051222 |
positive regulation of protein transport
|
ACHE, APP, EGFR, GPER1, GSK3B, MIF, MMP12, SMAD3, SRC |
2.1488 |
[BP] GO:0023014 |
signal transduction by protein phosphorylation
|
EGFR, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, TEK |
2.1426 |
[BP] GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling
|
FLT3, GPER1, KDR, TEK |
2.13898 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA2A, EGFR, GPER1, SLC6A4 |
2.13887 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA2A, EGFR, GPER1, SLC6A4 |
2.13887 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
AR, CA2, EGFR, ESR1, MET, SMAD3, SRC |
2.13887 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.13291 |
[BP] GO:0005979 |
None
|
ESRRB, GSK3B, INSR |
2.13291 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.13291 |
[BP] GO:0006693 |
None
|
CES2, MIF, PTGES |
2.13291 |
[BP] GO:0006692 |
None
|
CES2, MIF, PTGES |
2.13291 |
[BP] GO:0010962 |
None
|
ESRRB, GSK3B, INSR |
2.13291 |
[BP] GO:0010564 |
regulation of cell cycle process
|
APP, AURKB, CDC25B, CSNK2A1, CYP1A1, EGFR, GPER1, HSPA1A, INSR, MIF, TERT |
2.13291 |
[BP] GO:0051248 |
None
|
APP, CSNK2A1, DUSP3, EGFR, FABP4, GPER1, HSPA1A, IGF1R, MIF, MMP9, PTPN1, RELA, SMAD3, SRC, XDH |
2.13291 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, SRC, TEK |
2.13291 |
[BP] GO:1900076 |
regulation of cellular response to insulin stimulus
|
ESRRA, PTPN1, RELA, SRC |
2.12974 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
CYP19A1, HSD17B3 |
2.12974 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.12974 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.12974 |
[BP] GO:1904062 |
None
|
ADRA2A, APP, CACNA1C, GPER1, GPR35, KCNH2, MMP9 |
2.10754 |
[BP] GO:1904646 |
cellular response to amyloid-beta
|
APP, GSK3B, IGF1R |
2.09299 |
[BP] GO:1903827 |
regulation of cellular protein localization
|
APP, AR, CSNK2A1, EGFR, GPER1, GSK3B, PTPN1, SMAD3, SRC, TERT |
2.09012 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, HSD17B3 |
2.08601 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, ADRA2A, CACNA1C, CYP19A1, EGFR, GPER1, MIF, MMP12, SLC6A4, SRC |
2.06675 |
[BP] GO:0045934 |
None
|
ADRA2A, AR, AURKB, ESR1, ESR2, ESRRA, FABP4, GPER1, HSPA1A, MMP12, PPARA, RELA, RORC, SMAD3, SRC, TERT |
2.06675 |
[BP] GO:1900182 |
positive regulation of protein localization to nucleus
|
APP, EGFR, SMAD3, SRC, TERT |
2.06675 |
[BP] GO:0046683 |
response to organophosphorus
|
APP, RELA, SLC6A4, TEK, TYR |
2.06675 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, ESR1, HSD17B3 |
2.05217 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA2A, EGFR, GPER1, SLC6A4 |
2.03849 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CYP1A1, CYP1A2, PTGES, RELA, SRC |
2.03709 |
[BP] GO:0001817 |
regulation of cytokine production
|
ADRA2A, AXL, CYP1B1, HSPA1A, MAP3K7, MIF, MMP12, RELA, SMAD3, SRC |
2.03709 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA2A, EGFR, GPER1, SLC6A4 |
2.02585 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.02507 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
ALOX15, MIF, PTGES |
2.01476 |
[BP] GO:0007176 |
None
|
ADORA1, ADRA2A, APP |
2.01476 |
[BP] GO:0052548 |
None
|
APP, CSNK2A1, F3, GPER1, MMP9, SMAD3, SRC, XDH |
2.01289 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.00812 |
[BP] GO:0042391 |
None
|
ADORA1, APP, CACNA1C, GPER1, GPR35, KCNH2, KDR, SRC |
2.00812 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, ALPL, APP, AR, AXL, CA12, CA14, CA2, CA4, CACNA1C, CSNK2A1, EGFR, ESR1, F10, F3, FLT3, GPER1, GPR35, GSK3B, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP2, PIM1, PTPN1, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT |
4.50271 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.48195 |
[CC] GO:0009986 |
cell surface
|
ACHE, APP, AXL, CA4, EGFR, F3, KCNH2, MET, MIF, SLC6A2, TEK |
3.03544 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APP, AR, AURKB, CA1, CA2, CA4, CA7, CACNA1C, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DUSP3, EGFR, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, GPER1, GSK3B, HSD17B1, HSD17B2, HSD17B3, HSPA1A, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MIF, MMP2, MMP9, PIM1, PTGES, PTPN1, RELA, SLC6A4, SMAD3, SRC, TERT, TYR, XDH |
3.03422 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX15, ALOX5, ALPL, APP, AR, AXL, CA12, CA14, CA2, CA4, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EGFR, ESR1, F10, F3, FLT3, FUT7, GPER1, GPR35, GSK3B, HSD17B2, HSD17B3, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP2, PIM1, PTGES, PTPN1, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TYR |
2.96128 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA2A, APP, AXL, CA4, F10, F3, FLT3, GPER1, GPR35, IGF1R, INSR, KDR, MET, SLC6A2, SLC6A4, TEK |
2.84575 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, AOX1, APP, AR, AURKB, AXL, CA1, CA2, CA4, CA6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GPER1, GSK3B, HSD17B3, HSPA1A, IGF1R, INSR, KDR, MAOA, MAP2K1, MAP3K7, MIF, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RELA, RORC, SHBG, SMAD3, SRC, TERT, TYR, XDH |
2.81556 |
[CC] GO:0005783 |
None
|
ADORA1, APP, CA4, CES1, CES2, CYP19A1, FLT3, GPER1, HSD17B3, HSPA1A, KDR, MAP2K1, PTPN1, XDH |
2.7707 |
[CC] GO:0045121 |
membrane raft
|
APP, EGFR, INSR, KDR, SLC6A2, SLC6A4, SRC, TEK |
2.76575 |
[CC] GO:0098857 |
membrane microdomain
|
APP, EGFR, INSR, KDR, SLC6A2, SLC6A4, SRC, TEK |
2.7494 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA2A, ALOX15, APP, AXL, CA2, CA4, CACNA1C, DUSP3, EGFR, F10, F3, FLT3, GPER1, GPR35, IGF1R, INSR, KCNH2, KDR, MET, SLC6A2, SLC6A4, SRC, TEK |
2.55393 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EGFR, F10, FLT3, GPER1, HSD17B2, HSD17B3, PTGES, PTPN1 |
2.47222 |
[CC] GO:0048471 |
perinuclear region of cytoplasm
|
ACHE, AKR1B1, APP, CA4, EGFR, GPER1, HSPA1A, KCNH2, PTGES, SRC, TYR |
2.44991 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.40058 |
[CC] GO:0098589 |
membrane region
|
APP, EGFR, INSR, KDR, SLC6A2, SLC6A4, SRC, TEK |
2.29439 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, ADRA2A, CA2, CA4, EGFR, TEK |
2.24214 |
[CC] GO:0043226 |
organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALPL, AOX1, APP, AR, AURKB, AXL, CA1, CA2, CA4, CA6, CACNA1C, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GPER1, GSK3B, HSD17B3, HSPA1A, IGF1R, INSR, KDR, MAOA, MAP2K1, MAP3K7, MIF, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RELA, RORC, SHBG, SMAD3, SRC, TERT, TYR, XDH |
2.16091 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, AOX1, APP, AR, CA1, CA12, CA2, CA4, CA6, CA7, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SMAD3, TYR, XDH |
13.9576 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EGFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GSK3B, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TYR, XDH |
12.278 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, DUSP3, EGFR, F10, F3, FLT3, FUT7, GSK3B, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTGES, PTPN1, SRC, TEK, TERT, TYR, XDH |
11.5262 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
9.9316 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC |
7.95417 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC |
7.95417 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSD17B1, RORC, SHBG |
7.52399 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC |
7.40163 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.2474 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA6, CA7, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, SMAD3 |
6.85093 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
6.61345 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F10, MAP3K7, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, TERT, TYR, XDH |
6.56973 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.54579 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, EGFR, GPER1, HSD17B1, IGF1R, INSR, SHBG |
6.31296 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA6, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, ESR1, ESR2, ESRRA, ESRRB, F10, MAP3K7, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, TERT, TYR, XDH |
6.3032 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
6.24139 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MET, SRC, TEK |
6.13248 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, GPR35, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, PPARA, RORC, SMAD3, TEK |
5.72835 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, PPARA, SLC6A4, SRC, TEK |
5.66109 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, GPER1, HSD17B1, PPARA, RORC, SHBG |
5.6358 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, RELA, SLC6A4, SMAD3, SRC |
5.63254 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
5.57667 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, PTPN1, RELA, SLC6A4, SMAD3, SRC |
5.52136 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, XDH |
5.49614 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, GPR35, IGF1R, INSR, KCNH2, KDR, MET, PPARA, RORC, TEK |
5.49407 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
5.41106 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HSD17B1, HSD17B2, HSD17B3, MAOA, TYR, XDH |
5.25306 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
5.07771 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK, TERT |
4.81936 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, GPR35, IGF1R, INSR, KCNH2, KDR, MET, PPARA, RORC, TEK |
4.64042 |
[MF] GO:0019899 |
enzyme binding
|
ADRA2A, APP, AR, AURKB, CDC25B, CYP1A1, CYP1A2, CYP2C19, DUSP3, EGFR, ESR1, ESR2, ESRRB, F3, GSK3B, HSPA1A, KCNH2, MET, MIF, PPARA, PTPN1, RELA, SLC6A4, SMAD3, SRC, TEK |
4.43418 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, GPR35, IGF1R, INSR, KCNH2, KDR, MET, PPARA, RORC, TEK |
4.43161 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, AOX1, APP, CSNK2A1, EGFR, ESR1, ESR2, FLT3, IGF1R, KCNH2, KDR, MAP3K7, MET, MIF, MMP9, RELA, SLC6A4, SMAD3, TERT, TYR, XDH |
4.32881 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2, GPER1 |
4.11792 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
3.92669 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, F10, F3, FLT3, GSK3B, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTPN1, SRC, TEK |
3.87106 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD17B1, HSD17B2, HSD17B3, XDH |
3.83228 |
[MF] GO:0043168 |
anion binding
|
ALOX15, AOX1, APP, AURKB, AXL, CSNK2A1, EGFR, F10, F3, FABP3, FABP4, FLT3, GSK3B, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, PTGES, RELA, SRC, TEK, XDH |
3.76994 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.66348 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, TYR |
3.61816 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.48201 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.33177 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA6, CA7 |
3.09385 |
[MF] GO:0005057 |
signal transducer activity, downstream of receptor
|
EGFR, INSR, KDR, MAP2K1, MAP3K7, SMAD3 |
3.08126 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, SRC |
2.98898 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.93127 |
[MF] GO:0008013 |
beta-catenin binding
|
AR, CSNK2A1, ESR1, GSK3B, SMAD3 |
2.838 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, SRC |
2.83675 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, HSD17B1, PTGES, SRC, XDH |
2.75666 |
[MF] GO:0008134 |
transcription factor binding
|
AR, ESR1, ESRRB, FLT3, GSK3B, PIM1, PPARA, RELA, SMAD3, SRC, TERT |
2.75355 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, ADRA2A, AOX1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, EGFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GSK3B, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, NUAK1, PIM1, PPARA, PTPN1, RELA, RORC, SHBG, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
2.7164 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.70506 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, TYR |
2.59485 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A4 |
2.53401 |
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.53401 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.40058 |
[MF] GO:0047485 |
None
|
CSNK2A1, HSPA1A, MAP2K1, RELA, TERT |
2.38787 |
[MF] GO:0019900 |
None
|
ADRA2A, AURKB, CDC25B, DUSP3, EGFR, ESR1, GSK3B, PTPN1, RELA, SMAD3, SRC |
2.38604 |
[MF] GO:0005524 |
ATP binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
2.36325 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.36125 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.29463 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.29463 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.29463 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.29463 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AOX1, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, GSK3B, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK, XDH |
2.29314 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
2.26744 |
[MF] GO:0001085 |
RNA polymerase II transcription factor binding
|
AR, ESR1, GSK3B, PPARA, SMAD3 |
2.24433 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, GSK3B, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
2.23748 |
[MF] GO:0019901 |
None
|
ADRA2A, CDC25B, DUSP3, EGFR, ESR1, GSK3B, PTPN1, RELA, SMAD3, SRC |
2.22352 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD17B1, HSD17B2, HSD17B3 |
2.20301 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.20143 |
[MF] GO:0046983 |
protein dimerization activity
|
ACHE, ADORA1, ADRA2A, AOX1, AR, AXL, EGFR, FLT3, KCNH2, RELA, SLC6A4, SMAD3, TERT, TYR, XDH |
2.13586 |
[MF] GO:0017171 |
serine hydrolase activity
|
ACHE, F10, F3, MMP1, MMP12, MMP2, MMP9 |
2.13291 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.12974 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD17B1, HSD17B2, HSD17B3 |
2.09299 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.06675 |
[MF] GO:0000978 |
None
|
AR, ESR1, ESR2, ESRRA, PPARA, RELA, RORC, SMAD3 |
2.04127 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD17B1, HSD17B2, HSD17B3 |
2.01476 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.01476 |
[MF] GO:0031625 |
None
|
EGFR, GSK3B, HSPA1A, KCNH2, RELA, SMAD3, SRC |
2.00924 |